RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats

American Journal of Pathology

Volumn 176, Issue 6, 2010, Pages 2669-2681

  Paranjpe, Shirish ^a   Bowen, William C ^a   Tseng, George C ^b   Luo, Jian Hua ^a   Orr, Anne ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CELL ANTIGEN; CYCLIN D1; CYCLIN E1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P21; SHORT HAIRPIN RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; LIVER CELL; LIVER REGENERATION; LIVER WEIGHT; MALE; MITOSIS; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SRC HOMOLOGY DOMAIN; UPREGULATION; ANIMAL; FISCHER 344 RAT; GENE EXPRESSION PROFILING; GENETICS; LIVER; LIVER RESECTION; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; GENE EXPRESSION PROFILING; HEPATECTOMY; LIVER; LIVER REGENERATION; MALE; MICROARRAY ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, INBRED F344; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 77953202698     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090605     Document Type: Article

References (71)

1. Michalopoulos GK: Liver regeneration. J Cell Physiol 2007, 213:286-300
2. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997, 276:60-66
3. Patijn GA, Lieber A, Schowalter DB, Schwall R, Kay MA: Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 1998, 28:707-716 (Pubitemid 28405420)
4. Bucher NL: Liver regeneration: an overview. J Gastroenterol Hepatol 1991, 6:615-624
5. Bucher NL, Patel U, Cohen S: Hormonal factors concerned with liver regeneration. Ciba Found Symp 1977, 55:95-107
6. Yang J, Chen S, Huang L, Michalopoulos GK, Liu Y: Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology 2001, 33:848-859
7. Mars WM, Liu ML, Kitson RP, Goldfarb RH, Gabauer MK, Michalopoulos GK: Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 1995, 21:1695-1701
8. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK: Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999, 59:3954-3960
9. Agarwal S, Zerillo C, Kolmakova J, Christensen JG, Harris LN, Rimm DL, Digiovanna MP, Stern DF: Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells. Br J Cancer 2009, 100:941-949
10. Jo M, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC: Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem 2000, 275:8806-8811
11. Presnell SC, Stolz DB, Mars WM, Jo M, Michalopoulos GK, Strom SC: Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells. Mol Carcinog 1997, 18:244-255
12. Scheving LA, Stevenson MC, Taylormoore JM, Traxler P, Russell WE: Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem Biophys Res Commun 2002, 290:197-203
13. Xu KP, Yu FS: Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Invest Ophthalmol Vis Sci 2007, 48:2242-2248
14. Seki E, Kondo Y, Iimuro Y, Naka T, Son G, Kishimoto T, Fujimoto J, Tsutsui H, Nakanishi K: Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. J Hepatol 2008, 48:237-245
15. Michalopoulos GK, Khan Z: Liver regeneration, growth factors, and amphiregulin. Gastroenterology 2005, 128:503-506
16. Rojas-Munoz A, Rajadhyksha S, Gilmour D, van Bebber F, Antos C, Rodriguez Esteban C, Nusslein-Volhard C, Izpisua Belmonte JC: ErbB2 and ErbB3 regulate amputation-induced proliferation and migration during vertebrate regeneration. Dev Biol 2009, 327:177-190
17. Carver RS, Stevenson MC, Scheving LA, Russell WE: Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology 2002, 123:2017-2027
18. Linggi B, Carpenter G: ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 2006, 16:649-656
19. Fausto N, Mead JE: Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest 1989, 60:4-13 (Pubitemid 19053513)
20. Mitchell C, Nivison M, Jackson LF, Fox R, Lee DC, Campbell JS, Fausto N: Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 2005, 280:2562-2568
21. Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, Avila MA: Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology 2005, 128:424-432
22. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M: The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 2007, 75:770-787
23. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R: Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995, 376:337-341
24. Dackor J, Strunk KE, Wehmeyer MM, Threadgill DW: Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos. Placenta 2007, 28:1211-1218
25. Van Buren G, 2nd, Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM: Effect of molecular therapeutics on liver regeneration in a murine model. J Clin Oncol 2008, 26:1836-1842
26. Natarajan A, Wagner B, Sibilia M: The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA 2007, 104:17081-17086
27. Fausto N, Campbell JS, Riehle KJ: Liver regeneration. Hepatology 2006, 43:S45-S53
28. Muller U: Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech Dev 1999, 82:3-21
29. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T: Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev 1996, 10:245-260 (Pubitemid 26058958)
30. Gkretsi V, Apte U, Mars WM, Bowen WC, Luo JH, Yang Y, Yu YP, Orr A, St-Arnaud R, Dedhar S, Kaestner KH, Wu C, Michalopoulos GK: Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology 2008, 48:1932-1941
31. Paranjpe S, Bowen WC, Bell AW, Nejak-Bowen K, Luo JH, Michalopoulos GK: Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 2007, 45:1471-1477
32. Higgins GM: A. RM: Experimental pathology of the liver, 1: restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931, 12:186-202
33. Smith TF, Waterman MS: Identification of common molecular subsequences. J Mol Biol 1981, 147:195-197
34. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408
35. Michalopoulos GK, Bowen WC, Mule K, Luo J: HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr 2003, 11:55-75
36. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868
37. Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN, Fesik SW: Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 2003, 100:6347-6352
38. Learn PA, Krishnegowda N, Talamantez J, Kahlenberg MS: Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell lines. J Surg Res 2006, 136:227-231
39. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL, 3rd: Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 1994, 269:14661-14665 (Pubitemid 24194029)
40. Stortelers C, van der Woning SP, Jacobs-Oomen S, Wingens M, van Zoelen EJ: Selective formation of ErbB-2/ErbB-3 heterodimers depends on the ErbB-3 affinity of epidermal growth factor-like ligands. J Biol Chem 2003, 278:12055-12063
41. Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F: Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. Mol Cancer Res 2007, 5:393-401
42. Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC: ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci USA 2005, 102:3788-3793
43. Sithanandam G, Smith GT, Fields JR, Fornwald LW, Anderson LM: Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: erbB3 versus Gab1. Am J Respir Cell Mol Biol 2005, 33:490-499
44. Soltoff SP, Carraway KL, 3rd, Prigent SA, Gullick WG, Cantley LC: ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 1994, 14:3550-3558 (Pubitemid 24160762)
45. Quesnelle KM, Boehm AL, Grandis JR: STAT-mediated EGFR signaling in cancer. J Cell Biochem 2007, 102:311-319
46. Yu H, Jove R: The STATs of cancer: new molecular targets come of age. Nat Rev Cancer 2004, 4:97-105 (Pubitemid 38198738)
47. Haura EB, Zheng Z, Song L, Cantor A, Bepler G: Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Clin Cancer Res 2005, 11:8288-8294 (Pubitemid 41746939)
48. Kim DJ, Kataoka K, Rao D, Kiguchi K, Cotsarelis G, Digiovanni J: Targeted disruption of Stat3 reveals a major role for follicular stem cells in skin tumor initiation. Cancer Res 2009, 69:7587-7594
49. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J: Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 2006, 66:2544-2552
50. Niu G, Wright KL, Ma Y, Wright GM, Huang M, Irby R, Briggs J, Karras J, Cress WD, Pardoll D, Jove R, Chen J, Yu H: Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 2005, 25:7432-7440
51. Woodworth CD, Michael E, Marker D, Allen S, Smith L, Nees M: Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol Cancer Ther 2005, 4:650-658
52. Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wustefeld T, Borlak J, Manns MP, Trautwein C: Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo. Hepatology 2006, 44:164-173
53. Greenbaum LE, Cressman DE, Haber BA, Taub R: Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration: implications for maintenance of the differentiated state during liver growth. J Clin Invest 1995, 96:1351-1365
54. Peng D, Fan Z, Lu Y, DeBlasio T, Scher H, Mendelsohn J: Antiepidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res 1996, 56:3666-3669 (Pubitemid 26272010)
55. Haga S, Ogawa W, Inoue H, Terui K, Ogino T, Igarashi R, Takeda K, Akira S, Enosawa S, Furukawa H, Todo S, Ozaki M: Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J Hepatol 2005, 43:799-807
56. Fausto N: Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: present and future. Am J Physiol 1999, 277:G917-G921
57. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA: MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316:1039-1043
58. Sergina NV, Moasser MM: The HER family and cancer: emerging molecular mechanisms and therapeutic targets. Trends Mol Med 2007, 13:527-534
59. Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM, Moasser MM: Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature 2007, 445:437-441
60. Baselga J, Swain SM: Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 2009, 9:463-475
61. Wheeler DL, Huang S, Kruser TJ, Nechrebecki MM, Armstrong EA, Benavente S, Gondi V, Hsu KT, Harari PM: Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members. Oncogene 2008, 27:3944-3956
62. Mazzone M, Comoglio PM: The Met pathway: master switch and drug target in cancer progression. FASEB J 2006, 20:1611-1621
63. Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK: Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation. Breast Cancer Res Treat 2006, 95:17-27
64. Mueller KL, Hunter LA, Ethier SP, Boerner JL: Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res 2008, 68:3314-3322
65. Ishizawar RC, Miyake T, Parsons SJ: c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 2007, 26:3503-3510
66. Minamishima YA, Nakayama K, Nakayama K: Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice. Cancer Res 2002, 62:995-999 (Pubitemid 34160276)
67. Nevzorova YA, Tschaharganeh D, Gassler N, Geng Y, Weiskirchen R, Sicinski P, Trautwein C, Liedtke C: Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. Gastroenterology 2009, 137:691-703
68. Laconi S, Pillai S, Porcu PP, Shafritz DA, Pani P, Laconi E: Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol 2001, 158:771-777 (Pubitemid 32158638)
69. Wiley HS: Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res 2003, 284:78-88
70. Orth JD, Krueger EW, Weller SG, McNiven MA: A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. Cancer Res 2006, 66:3603-3610
71. Haga S, Ozaki M, Inoue H, Okamoto Y, Ogawa W, Takeda K, Akira S, Todo S: The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide- dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation. Hepatology 2009, 49:204-214